Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
mercoledì, novembre 18
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
SELLAS Life Sciences Group Inc
SLS
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$19.15
11.68
156.36%
In chiusura: Nov 17, 4:00 PM EST
$17.10
-2.05
-10.7%
Post-mercato: 7:48 PM EST
Get Report
Panoramica
Notizie
Grafici
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
PRO
Perché si muove?:
SELLAS Life Sciences shares are trading higher after the company announced ...
Utili:
I risultati di Q3 2026 sono stati pubblicati in data gio nov 12th, dopo la chiusura del mercato
SELLAS Life Sciences Gr Financials
SELLAS Life Sciences Gr (SLS) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Dow Falls Over 200 Points; US Retail Sales Rise 0.2% In October
U.S. stocks were mixed as the Dow fell 200+ points; retail sales rose 0.2%, oil gained 1.5%, and SLS surged 177%.
Avi Kapoor
PRO
SELLAS Life Sciences Gr Q3 EPS $(0.05), Inline
SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last
Benzinga Newsdesk
PRO
SELLAS Life Sciences Gr Q2 EPS $(0.05) Misses $(0.04) Estimate
SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.04) by 25 percent. This is a 28.57 percent increase over losses of $(0.07) per share
Benzinga Newsdesk
PRO
SELLAS Life Sciences Gr Q1 EPS $(0.05) Beats $(0.06) Estimate
SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 28.57 percent increase over losses of $(0.07) per share
Benzinga Newsdesk
PRO
SELLAS Life Sciences Gr Q4 EPS $(0.05) Beats $(0.07) Estimate
SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 37.5 percent increase over losses of $(0.08) per share
Benzinga Newsdesk
PRO
SELLAS Life Sciences Gr Q3 EPS $(0.06) Beats $(0.09) Estimate
SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.09) by 29.41 percent. This is a 40 percent increase over losses of $(0.10) per share
Benzinga Newsdesk